MC

BIOLOGICAL3 trials

Sponsors

Aivita Biomedical, Inc., Universidade Estadual Paulista Júlio de Mesquita Filho

Conditions

Fallopian Tube CarcinomaGingival RecessionPrimary Peritoneal CarcinomaStage III Ovarian CarcinomaStage IV Ovarian Carcinoma

Phase 2

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

Aivita Biomedical, Inc.Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage III Ovarian Carcinoma +1

Start: 2017-11-18End: 2023-03-31Target: 99Updated: 2022-04-25

Unknown Phase

Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical Lesion

CompletedNCT03341598

Universidade Estadual Paulista Júlio de Mesquita FilhoGingival Recession

Start: 2017-02-01End: 2018-07-27Updated: 2020-09-02

Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap

CompletedNCT03667105

Universidade Estadual Paulista Júlio de Mesquita FilhoGingival Recession

Start: 2018-08-15End: 2020-02-25Updated: 2020-05-01

Related Papers

Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine

Advanced Science2025-03-262 citations

Randomized phase 2 trial of personal dendritic cell (DC)-autologous tumor antigen (ATA) vaccines in newly diagnosed advanced ovary cancer.

Journal of Clinical Oncology2023-06-01

Single gingival recession associated with non‐carious cervical lesion treated by partial restoration and coronally advanced flap with or without xenogenous collagen matrix: A randomized clinical trial evaluating the coverage procedures and restorative protocol

Journal of Periodontology2021-07-2626 citations

Abstract CT189: Patient-specific dendritic cell vaccines with tumor antigens from self-renewing autologous tumor cells in the treatment of primary advanced ovarian cancer: A multi-institutional phase II clinical trial

Cancer Research2020-08-15

Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.

Journal of Clinical Oncology2019-03-10